Frontiers in Aging Neuroscience

《衰老神经科学前沿》是一本前沿的多学科期刊，旨在促进对中枢神经系统衰老和与年龄相关的神经疾病相关的机制过程的理解。该杂志的另一个核心作用是，将专注于理解衰老基本过程的学科和理论结合起来。特别强调整合神经科学各子学科的研究成果，对衰老过程和与衰老相关的神经系统疾病进行转化研究，并制定旨在保护神经功能的治疗策略。这方面对于提高我们理解、管理和治疗与衰老相关的疾病的能力至关重要。由于该杂志的综合性，将考虑的文章范围是广泛的，包括阐明遗传、生物物理、基因组、蛋白质组、细胞、分子、生化、内分泌、免疫学、生理学、药理学和心理/行为方面的CNS老化和神经系统疾病和病理事件与此过程相关的工作。也欢迎针对神经老化/疾病机制方面的神经影像学研究和临床研究。提交作者须知对于涉及动物和人类衰老和年龄相关神经系统疾病领域的机械和介入研究的基础研究(神经影像学临床试验、年龄相关疾病的生物标志物或延迟年龄干预措施)，请在求职信中注明，您提交的材料将在我们的临床前/转化部门考虑。如果你的手稿包括临床研究中枢神经系统related-related发生的变化与衰老和年龄相关的神经系统疾病(神经系统功能的变化,发生在整个寿命或比较和正常年龄中枢神经系统病变的功能),请注明你提交的求职信的目的是为临床部门。

Frontiers in Aging Neuroscience is a cutting-edge multidisciplinary journal aimed at fostering the understanding of mechanistic processes associated with CNS aging and age-related neuronal diseases. Another central role of the journal is to bring cohesion between disciplines and theories focused on understanding the fundamental processes of senescence. Special emphasis is placed on integrating findings of various sub disciplines in neuroscience to yield translational insight to the aging process and neurological diseases associated with senescence, and developing treatment strategies aimed at the conservation of neuronal function. This aspect is critical to advance our ability to understand, manage, and treat conditions associated with aging. Because of the integrative nature of the journal, the scope of articles that will be considered is broad, and includes work elucidating genetic, biophysical, genomic, proteomic, cellular, molecular, biochemical, endocrinal, immunological, physiological, pharmacological, and psychological/behavioral aspects of CNS aging and neurological diseases and pathological events connected to this process. Neuroimaging studies and clinical studies targeted to mechanistic aspects of neuronal aging/disease are also welcome.Instructions for Submitting AuthorsFor basic research involving mechanistic and intervention-based studies within the field of aging and age-related neurological diseases in animals and humans (clinical trials with neuroimaging, biomarkers for age-related disease or age-delaying interventions), please indicate in the cover letter that your submission is intended for consideration within our pre-clinical/translational division. If your manuscript involves clinical research on CNS related-related changes that occur with aging and age-related neurological diseases (changes in neurological function that occur across the lifespan or comparisons and normal aged to diseased CNS function), please indicate in the cover letter that your submission is intended for our clinical division.